Actuate Therapeutics Inc
(ACTU)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,674 | -12,266 | -6,317 | -27,285 | -20,839 |
| Accounts payable and accrued liabilities | -698 | 1,130 | 622 | -1,501 | -1,198 |
| Other Working Capital | -2,317 | 759 | 568 | 1,100 | 623 |
| Other Operating Activity | 5,218 | 1,584 | 508 | 5,843 | 4,344 |
| Operating Cash Flow | $-15,470 | $-8,793 | $-4,619 | $-21,843 | $-17,070 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 200 | 200 |
| Debt Issued | N/A | N/A | 0 | 5,500 | 5,500 |
| Common Stock Issued | 24,027 | 6,819 | N/A | 23,957 | 23,957 |
| Other Financing Activity | -274 | -175 | -134 | -2,131 | -2,022 |
| Financing Cash Flow | $23,753 | $6,644 | $-134 | $27,526 | $27,635 |
| Beginning Cash Position | 8,642 | 8,642 | 8,642 | 2,959 | 2,959 |
| End Cash Position | 16,925 | 6,493 | 3,889 | 8,642 | 13,524 |
| Net Cash Flow | $8,283 | $-2,149 | $-4,752 | $5,683 | $10,565 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,470 | -8,793 | -4,619 | -21,843 | -17,070 |
| Free Cash Flow | -15,470 | -8,793 | -4,619 | -21,843 | -17,070 |